secwatch / observer
8-K filed September 1, 2023, 7:59 PM ET ticker MAIA CIK 0001878313
other material confidence high sentiment neutral materiality 0.55

MAIA Biotechnology enters $7M ATM equity facility with ThinkEquity LLC

MAIA Biotechnology, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MAIA Biotechnology, Inc. entered into Sales Agreement with ThinkEquity LLC valued at up to $7,000,000 (effective 2023-09-01).

Action
entry
Agreement
atm program
Counterparty
ThinkEquity LLC
Value
up to $7,000,000
Effective
2023-09-01
Exact text from the filing
On September 1, 2023, MAIA Biotechnology, Inc. (the “Company”), entered into an “at-the-market” Sales Agreement (the “Sales Agreement”) with ThinkEquity LLC (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agent, shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $7,000,000, subject to the terms and conditions of the Sales Agreement.
View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

MAIA Biotechnology, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-227712
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.